Predicting cardiovascular disease risk from gut microbial genes

Area of Science:

• Microbiology
• Metagenomics
• Cardiovascular Health

Background:

• Gut bacteria produce trimethylamine (TMA), a metabolite strongly associated with cardiovascular disease.
• Understanding TMA metabolism is crucial for addressing TMA-related health conditions.

Purpose of the Study:

• To comprehensively catalog pathways involved in TMA metabolism.
• To identify key bacterial players in TMA production and metabolism.
• To link gut microbial gene content to fecal TMA concentrations and cardiovascular disease risk.

Main Methods:

• Development and utilization of the Methylated Amine Gene Inventory of Catabolism database (MAGICdb).
• Integration of transcriptomics, proteomics, and metagenomic data.
• Analysis of gut microbial gene content and its correlation with fecal TMA levels.

Main Results:

• Identified key bacterial players and pathways in TMA metabolism.
• Methylated amine metabolism is a keystone microbiome process performed by a subset of the gut microbiota.
• Discovered new TMA-reducing genera with potential for probiotic or microbiome interventions.
• MAGICdb demonstrated comparable cardiovascular disease risk prediction to traditional lipid-based factors.

Conclusions:

• MAGICdb is a valuable open-source tool for studying TMA metabolism in the gut microbiome.
• This research links gut microbial gene content to TMA production and cardiovascular health.
• Findings support the development of targeted microbiome interventions for cardiovascular disease prevention.